Nateglinide (AvKARE, Inc.)


Welcome to the PulseAid listing for the Nateglinide drug offered from AvKARE, Inc.. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AvKARE, Inc.
NON-PROPRIETARY NAME: Nateglinide
SUBSTANCE NAME: NATEGLINIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Glinide [EPC],Potassium Channel Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-04-06
END MARKETING DATE: 0000-00-00


Nateglinide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNateglinide from AvKARE, Inc.
LABELER NAME: AvKARE, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 60(mg/1)
START MARKETING DATE: 2016-04-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42291-636_ade26270-43a3-d0bb-0597-55d0e095c74c
PRODUCT NDC: 42291-636
APPLICATION NUMBER: ANDA077463

Other NATEGLINIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Nateglinide
American Health PackagingNateglinide
Avera McKennan HospitalNateglinide
AvKARE, Inc.Nateglinide
Cadila Healthcare LimitedNateglinide
Dr. Reddy’s Laboratories LimitedNateglinide
Golden State Medical Supply, Inc.Nateglinide
NCS HealthCare of KY, Inc dba Vangard LabsNateglinide
Novartis Pharmaceuticals CorporationStarlix
Par Pharmaceutical, Inc.Nateglinide
Physicians Total Care, Inc.Nateglinide
Zydus Pharmaceuticals (USA) Inc.Nateglinide